UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 21, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 21, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 1,189 Common Stock at $512.71 ($609,617) on August 21, 2026; holds 332,754 after (Indirect).
- Open-market sale: disposed of 271 Common Stock at $513.85 ($139,254) on August 21, 2026; holds 332,483 after (Indirect).
- Open-market sale: disposed of 624 Common Stock at $515.26 ($321,524) on August 21, 2026; holds 331,859 after (Indirect).
- Open-market sale: disposed of 1,689 Common Stock at $516.15 ($871,777) on August 21, 2026; holds 330,170 after (Indirect).
- Open-market sale: disposed of 773 Common Stock at $517.07 ($399,695) on August 21, 2026; holds 329,397 after (Indirect).
- Open-market sale: disposed of 1,077 Common Stock at $518.14 ($558,032) on August 21, 2026; holds 328,320 after (Indirect).
- Open-market sale: disposed of 837 Common Stock at $519.09 ($434,474) on August 21, 2026; holds 327,483 after (Indirect).
- Open-market sale: disposed of 440 Common Stock at $520.03 ($228,814) on August 21, 2026; holds 327,043 after (Indirect).
- Open-market sale: disposed of 371 Common Stock at $521.28 ($193,395) on August 21, 2026; holds 326,672 after (Indirect).
- Open-market sale: disposed of 669 Common Stock at $522.29 ($349,411) on August 21, 2026; holds 326,003 after (Indirect).
- Open-market sale: disposed of 455 Common Stock at $523.62 ($238,247) on August 21, 2026; holds 325,548 after (Indirect).
- Open-market sale: disposed of 625 Common Stock at $524.35 ($327,720) on August 21, 2026; holds 324,923 after (Indirect).
- Open-market sale: disposed of 235 Common Stock at $525.42 ($123,474) on August 21, 2026; holds 324,688 after (Indirect).
- Open-market sale: disposed of 45 Common Stock at $526.47 ($23,691) on August 21, 2026; holds 324,643 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $527.71 ($105,542) on August 21, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 21, 2026; holds 84,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,924,666 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-21 | Open-market sale | Common Stock | 1,189 | $513 | $609.6K | 332,754 |
| 2026-08-21 | Open-market sale | Common Stock | 271 | $514 | $139.3K | 332,483 |
| 2026-08-21 | Open-market sale | Common Stock | 624 | $515 | $321.5K | 331,859 |
| 2026-08-21 | Open-market sale | Common Stock | 1,689 | $516 | $871.8K | 330,170 |
| 2026-08-21 | Open-market sale | Common Stock | 773 | $517 | $399.7K | 329,397 |
| 2026-08-21 | Open-market sale | Common Stock | 1,077 | $518 | $558.0K | 328,320 |
| 2026-08-21 | Open-market sale | Common Stock | 837 | $519 | $434.5K | 327,483 |
| 2026-08-21 | Open-market sale | Common Stock | 440 | $520 | $228.8K | 327,043 |
| 2026-08-21 | Open-market sale | Common Stock | 371 | $521 | $193.4K | 326,672 |
| 2026-08-21 | Open-market sale | Common Stock | 669 | $522 | $349.4K | 326,003 |
| 2026-08-21 | Open-market sale | Common Stock | 455 | $524 | $238.2K | 325,548 |
| 2026-08-21 | Open-market sale | Common Stock | 625 | $524 | $327.7K | 324,923 |
| 2026-08-21 | Open-market sale | Common Stock | 235 | $525 | $123.5K | 324,688 |
| 2026-08-21 | Open-market sale | Common Stock | 45 | $526 | $23.7K | 324,643 |
| 2026-08-21 | Open-market sale | Common Stock | 200 | $528 | $105.5K | 324,443 |
| 2026-08-21 | Option exercise/conversion | Stock Option | 9,500 | — | — | 84,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Option exercise/conversion (9,500 shares) |
| 2026-08-21 | Open-market sale (1,189 shares) |
| 2026-08-21 | Open-market sale (271 shares) |
| 2026-08-21 | Open-market sale (624 shares) |
| 2026-08-21 | Open-market sale (1,689 shares) |
| 2026-08-21 | Open-market sale (773 shares) |
| 2026-08-21 | Open-market sale (1,077 shares) |
| 2026-08-21 | Open-market sale (837 shares) |
| 2026-08-21 | Open-market sale (440 shares) |
| 2026-08-21 | Open-market sale (371 shares) |
| 2026-08-21 | Open-market sale (669 shares) |
| 2026-08-21 | Open-market sale (455 shares) |
| 2026-08-21 | Open-market sale (625 shares) |
| 2026-08-21 | Open-market sale (235 shares) |
| 2026-08-21 | Open-market sale (45 shares) |
| 2026-08-21 | Open-market sale (200 shares) |
| 2026-08-21 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.